Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Oklo Inc.CL A(OKLO) | 6,920,804 | 6,920,804 | 0 | $58.62M | $55.99M | 34.25% | -$2.63M |
| Evolv Technologies Holdings, Inc.CL A(EVLV) | 9,681,281 | 9,681,281 | 0 | $24.69M | $39.21M | 23.99% | +$14.52M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 5,941,120 | 5,941,120 | 0 | $44.56M | $39.15M | 23.95% | -$5.41M |
| Rocket Lab USA, Inc. | 2,929,350 | 2,929,350 | 0 | $14.06M | $28.50M | 17.44% | +$14.44M |
| Mind Medicine (MindMed) Inc. | 100,350 | 100,350 | 0 | $723.5K | $571.0K | 0.35% | -$152.5K |
| Roivant Sciences Ltd.SHS(ROIV) | 3,875 | 3,875 | 0 | $41.0K | $44.7K | 0.03% | +$3.8K |